AutoGenomics Sets IPO Pricing Range

Vista, California-based AutoGenomics, which manufactures molecular diagnostics systems, has set its estimated initial public offering range, saying it expects to sell 3.75 million shares of its common stock at between $11.00 and $13.00 per share. The company filed earlier to list on the NASDAQ Global Market as AGMX. The offering would net the company around $56.0M on the public markets.